Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers
Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab)...
11-Jul-2018 12:00 PM EDT
Add to Favorites
Ludwig-Developed Candidate Cancer Drug May Be Effective Against Broader Class of Brain Cancers
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer...
9-Jul-2018 4:15 PM EDT
Add to Favorites
How Might Baking Soda Boost Cancer Therapy?
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute...
25-May-2018 12:00 PM EDT
Add to Favorites
ASCO to Honor Ludwig Scientists at 2018 Annual Meeting
The American Society of Clinical Oncology (ASCO) will honor two Ludwig scientists at its 2018 Annual Meeting in Chicago, Ill., June 1-5, 2018.
30-May-2018 9:00 AM EDT
Add to Favorites
Ludwig Scientists Share New Findings on Personalized Cancer Treatments, Immunotherapy and the Tumor Microenvironment at 2018 AACR Annual Meeting
Ludwig Cancer Research released today the full scope of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, Ill., April 14-18, 2018. Research conducted by more...
11-Apr-2018 4:00 PM EDT
Add to Favorites
Ludwig Researchers Devise and Test Pioneering Personalized Cancer Vaccine for Ovarian Cancer
A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and...
10-Apr-2018 6:00 PM EDT
Add to Favorites
Ludwig Study Extends the Potential for Personalized Immunotherapy to a Large Variety of Cancers
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently available immunotherapies, could be susceptible to personalized immunotherapy. Led by Ludwig Lausanne investigator Alexandre Harari and George Coukos,...
15-Mar-2018 6:00 AM EDT
Add to Favorites
Ludwig Researchers Uncover Mechanism Behind a Metabolic Vulnerability of Certain Breast Cancers
Many cancer cells are relatively sensitive to the deprivation of an essential amino acid known as methionine. Now, a Ludwig Cancer Research study published in the journal Science Signaling and led by Alex Toker, an investigator in the Ludwig Center...
19-Dec-2017 2:00 PM EST
Add to Favorites
see all news
